Osseous Technologies of America, Inc. v. DiscoveryOrtho Partners LLC

191 Cal. App. 4th 357, 119 Cal. Rptr. 3d 346, 2010 Cal. App. LEXIS 2168
CourtCalifornia Court of Appeal
DecidedDecember 28, 2010
DocketNo. G042747
StatusPublished
Cited by28 cases

This text of 191 Cal. App. 4th 357 (Osseous Technologies of America, Inc. v. DiscoveryOrtho Partners LLC) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Osseous Technologies of America, Inc. v. DiscoveryOrtho Partners LLC, 191 Cal. App. 4th 357, 119 Cal. Rptr. 3d 346, 2010 Cal. App. LEXIS 2168 (Cal. Ct. App. 2010).

Opinion

Opinion

IKOLA, J.

Faced with accusations it was breaching a services agreement by failing to pay what it allegedly owed for services rendered, Osseous Technologies of America, Inc. (Osseous), sued for declaratory relief (Code Civ. Proc., § 1060)1 rather than waiting for a breach of contract action to be filed against it. Defendant DiscoveryOrtho Partners LLC (DiscoveryOrtho) demurred to the complaint on the grounds the trial court should exercise its discretion under section 1061 to “refuse to exercise the power” to decide declaratory relief actions. In sustaining the demurrer, the court reasoned declaratory relief would not be “necessary or proper at the time under all the circumstances” (§ 1061) because the facts as pleaded amounted to a breach of contract dispute (looking to past conduct) rather than a forward-looking pronouncement of the rights and duties of the parties. The court did not abuse its discretion by sustaining the demurrer without leave to amend and entering judgment accordingly.

FACTS

“On appeal from a judgment dismissing an action after sustaining a demurrer without leave to amend . . . [w]e give the complaint a reasonable interpretation, reading it as a whole and its parts in their context. [Citation.] Further, we treat the demurrer as admitting all material facts properly pleaded, but do not assume the truth of contentions, deductions or conclusions of law.” (City of Dinuba v. County of Tulare (2007) 41 Cal.4th 859, 865 [62 Cal.Rptr.3d 614, 161 P.3d 1168].) We therefore base our recitation of the underlying facts on the facts pleaded in Osseous’s complaint for declaratory relief and attachments thereto.

Dispute Between Osseous and DiscoveryOrtho

Osseous “develops and markets innovative, high quality products for surgeons and restorative clinicians in dental and sinus surgery sectors.” Osseous believed one such technology to be particularly promising, with [361]*361possible applications beyond dental and sinus surgery. “To that end, [Osseous] became interested in seeking out an asset sale or license with medical device manufacturers for its existing . . . technology.”

Osseous entered into a written marketing agreement (which Osseous attached to the complaint) with DiscoveryOrtho on December 3, 2008. The marketing agreement pertained to the promising Osseous technology noted above. Osseous disclosed it had begun discussions with Medtronic (a prominent medical technology company) regarding the Osseous technology. Osseous indicated it would like DiscoveryOrtho to “[p]rovide outreach/introductions/ interface to [potential] licensing partners i.e. Stryker, Globus, Synthes, and Zimmer etc.”

Pursuant to the marketing agreement, DiscoveryOrtho agreed to “1. Identify Potential Strategic Partners, [f] 2. Provide Market Outreach to those strategic partners in presenting the licensing opportunity. [][] 3. Facilitate further discussions with Medtronic management and assist in negotiating a licensing/acquisition agreement if possible. [][] 4. Evaluate/Negotiate term sheet in conjunction with Osseous with a potential non-Medtronic strategic partner. [][] DiscoveryOrtho will present Osseous a summary target list of potential strategic licensing partners within 2 weeks of beginning the project and will update Osseous on its outreach efforts weekly.”

Osseous’s obligations under the marketing agreement pertained to exclusivity and fees. The exclusivity provision stated: “Osseous agrees to work with DiscoveryOrtho exclusively for a six month period, renewable for an additional three months if mutually agreed by DiscoveryOrtho . . . and Osseous. However, if during the conclusion of the six month term, a term sheet is actively under consideration or an introduction made by [DiscoveryOrtho] reemerges as an interested party at a later date, [DiscoveryOrtho]/Osseous will continue to abide by the terms of the agreement in good faith.” The fee provision allocated “a percentage of the total value of the final license or asset sale transaction” to DiscoveryOrtho. The parties agreed to one fee formula for a Medtronic transaction, then provided: “The percentage paid to DiscoveryOrtho on a non-Medtronic license or acquisition would be 5% of the transaction/gross consideration of up to $25 million plus 9% on any incremental gross amount from $25 million and above.”

“On or about December 5, 2008, two days after entering the [marketing] agreement, [Osseous’s] President, William Knox, on his own initiative and unassisted by [DiscoveryOrtho], made contact and began discussions with [362]*362Zimmer Dental, Inc. (‘Zimmer’) regarding [Osseous’s] existing . . . technology and products. Thereafter, [DiscoveryOrtho] provided consulting services pursuant to the Agreement designed to assist [Osseous] in its negotiations with Zimmer.”

“On or about February 1, 2009, [DiscoveryOrtho] and [Osseous] entered into a [contract addendum], [f] Pursuant to the Addendum, [Osseous] recognized that [DiscoveryOrtho’s] ‘creation of new product designs/applications for the [technology] created additional value to [Osseous]’ and agreed to pay [DiscoveryOrtho] 8.5% of the total transaction/gross consideration for any license, IP acquisition, distribution or co-development agreement on such new product designs or applications.”

“In or about June 2009, [Osseous] reached a Distribution Agreement with Zimmer . . . regarding [Osseous’s] existing . . . technology and products . . . .” Citing a confidentiality agreement, Osseous did not attach the Zimmer distribution agreement to the complaint or quote its key provisions. Instead, Osseous characterized it as not “involv[ing] an asset sale or upfront license, or [DiscoveryOrtho’s] creation of any new product designs or applications.”

“[DiscoveryOrtho] sent [Osseous] an invoice on or about June 23, 2009, demanding that [Osseous] pay [DiscoveryOrtho] exorbitant sums for upfront payments, milestones, royalties, yearly mínimums, product transfer prices and call options all based at the 8.5% rate specified in the Addendum and extending over the entire life of the Zimmer Distribution Agreement . . . .” Osseous “disputed, and hereby again disputes, the Invoice and the amounts stated thereon and/or that any account has been stated between [Osseous] and [DiscoveryOrtho] for any of those amounts.” The invoice, attached to the complaint, indicates a $2.25 million upfront payment was due, and set forth a schedule (stretching over at least five years) for additional payments.

Procedural History

The July 2, 2009 complaint avers an actual controversy exists as to “whether [DiscoveryOrtho] is entitled to any payment from [Osseous] pursuant to the Agreement or Addendum for any consulting services provided by [DiscoveryOrtho] to [Osseous] in connection with or in assistance to the Zimmer Distribution Agreement.” The prayer for relief requests a declaration on multiple questions pertaining to the interpretation of the DiscoveryOrtho agreement (with addendum) and its applicability to the Zimmer distribution agreement. The complaint contends neither the agreement nor the addendum applies to the Zimmer distribution agreement. The complaint further contends DiscoveryOrtho’s “recovery of any amount for its services should be limited [363]*363to and measured on a quantum meruit basis for the reasonable value of the services provided by [DiscoveryOrtho] in connection with the Zimmer Distribution Agreement.”

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Caglia Environmental v. City of Selma CA5
California Court of Appeal, 2026
Cardenas Markets v. The Continental Corp. CA4/1
California Court of Appeal, 2026
City of Gilroy v. Superior Court
California Supreme Court, 2026
Bauer v. Likhterman CA4/3
California Court of Appeal, 2026
Trellis Research v. Thaler CA2/2
California Court of Appeal, 2025
Ilumin v. Leach CA1/2
California Court of Appeal, 2024
Heresniak v. Musk
N.D. California, 2023
Cordoba Corp. v. City of Industry
California Court of Appeal, 2023
Yellow Dog Holdings v. Ascentium Capital CA4/3
California Court of Appeal, 2022
Liebovich v. Tobin CA2/2
California Court of Appeal, 2021
City of San Diego v. Nelson CA4/1
California Court of Appeal, 2021
Abatti v. Imperial Irrigation District
California Court of Appeal, 2020
Abatti v. Imperial Irrigation Dist.
California Court of Appeal, 2020

Cite This Page — Counsel Stack

Bluebook (online)
191 Cal. App. 4th 357, 119 Cal. Rptr. 3d 346, 2010 Cal. App. LEXIS 2168, Counsel Stack Legal Research, https://law.counselstack.com/opinion/osseous-technologies-of-america-inc-v-discoveryortho-partners-llc-calctapp-2010.